WallStreetZenWallStreetZen

NYSEMKT: INFU
Infusystem Holdings Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

INFU past earnings growth

How has INFU's earnings growth performed historically?
Company
N/A
Industry
22.79%
Market
107.64%
INFU's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
INFU's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

INFU past revenue growth

How has INFU's revenue growth performed historically?
Company
14.44%
Industry
7.99%
Market
17.61%
INFU's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INFU's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INFU's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INFU earnings and revenue history

Current Revenue
$125.8M
Current Earnings
$872.0k
Current Profit Margin
0.7%
INFU's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

INFU Return on Equity

Current Company
1.7%
Current Industry
11.1%
Current Market
188%
INFU's Return on Equity (1.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when INFU announces earnings.

INFU Return on Assets

Current Company
0.9%
Current Industry
7.2%
INFU is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INFU Return on Capital Employed

Current Company
4.61%
Current Industry
9.7%
INFU's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INFU vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INFU$125.79M$16.53M$872.00k+13.38%-13.06%
HBIO$112.25M$8.03M-$3.42M-1.45%N/A
AKYA$96.63M-$45.63M-$63.32M+22.99%N/A
STXS$26.77M-$20.09M-$22.06M-1.82%N/A
ZTEK$24.90k-$8.44M-$8.87M-58.51%N/A
View Top Medical Stocks

INFU earnings dates

Next earnings date
May 2, 2024

Infusystem Holdings Earnings & Revenue FAQ

What were INFU's earnings last quarter?

On Invalid Date, Infusystem Holdings (NYSEMKT: INFU) reported Q4 2023 earnings per share (EPS) of $0.00, up N/A year over year. Total Infusystem Holdings earnings for the quarter were $72.00 thousand. In the same quarter last year, Infusystem Holdings's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Infusystem Holdings stock.

What was INFU's earnings growth in the past year?

As of Q2 2024, Infusystem Holdings's earnings has grown year over year. Infusystem Holdings's earnings in the past year totalled $872.00 thousand.

What is INFU's earnings date?

Infusystem Holdings's earnings date is Invalid Date. Add INFU to your watchlist to be reminded of INFU's next earnings announcement.

What was INFU's revenue last quarter?

On Invalid Date, Infusystem Holdings (NYSEMKT: INFU) reported Q4 2023 revenue of $31.77 million up 10.2% year over year. In the same quarter last year, Infusystem Holdings's revenue was $28.83 million.

What was INFU's revenue growth in the past year?

As of Q2 2024, Infusystem Holdings's revenue has grown 14.44% year over year. This is 6.45 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.99%. Infusystem Holdings's revenue in the past year totalled $125.79 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.